Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore which performs better: index funds or mutual funds, focusing on costs, tracking error, and long-term results for investors.
24,353 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
In a market where mortgage rates wobble and volumes shift, brokerages lean on tech stacks matter, culture to accelera...
Want to protect cash flow while staying on the right side of the law? This guide shows real estate investors legally ...
Kalshi filed a federal lawsuit against Illinois and Governor Pritzker, challenging the state’s new prediction markets...
Meta documents reveal plans to launch an AI-powered prediction market app using play money. The move could reshape ho...
MemeCore’s M token plunged 76% in 24 hours, while MIM depegged to $0.50, triggering emergency measures by its develop...
SpaceX remains privately held, but chatter about a public listing fuels the myth that a superstar IPO will power the ...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
The case centers on retired firefighter with $810,000 in savings who discovers Medicare IRMAA surcharges after a lump...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
US-regulated crypto perps are live, moving from approval to execution as Kalshi launches a multi-asset perpetual futu...
When a CEO sells a sizable chunk of stock, investors take notice. This article dives into the details behind trulieve...